Breast Lumpectomy Clinical Trials Breast Lumpectomy RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
Conditions:   Estrogen Receptor Negative;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Progesterone Receptor Negative;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Triple-Negati ve Breast Carcinoma Interventions:   Drug: Atezolizumab;   Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Procedure: Lumpectomy;   Procedure: Mastectomy;   Drug: Paclitaxel Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2016 Category: Research Source Type: clinical trials

CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer
Condition:   Breast CarcinomaInterventions:   Behavioral: Behavioral Dietary Intervention;   Procedure: Lumpectomy;   Procedure: MastectomySponsor:   Thomas Jefferson UniversityNot yet recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 13, 2016 Category: Research Source Type: clinical trials

MRI-Based Preoperative Accelerated Partial Breast Irradiation
Condition:   Breast CancerIntervention:   Other: Phase II - Preoperative Radiation followed by Lumpectomy.Sponsor:   Medical College of WisconsinNot yet recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2016 Category: Research Source Type: clinical trials